Hypersensitivity to the active substance, to soya, or to any of the excipients listed in Description.
Pregnancy (see Use in Pregnancy & Lactation).
Women of child-bearing potential who are not using reliable contraception (see Precautions and Use in Pregnancy & Lactation).
Breast-feeding (see Use in Pregnancy & Lactation).
Severe hepatic impairment (with or without cirrhosis) (see Dosage & Administration).
Baseline values of hepatic aminotransferases (aspartate aminotransferases (AST) and/or alanine aminotransferases (ALT)) >3xULN (see Dosage & Administration and Precautions).
Idiopathic pulmonary fibrosis (IPF), with or without secondary pulmonary hypertension (see Pharmacology: Pharmacodynamics under Actions).